Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ — CEO Dr Martin Edlund: “As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and positive spirit than ever to deliver renewable tidal energy to the world” Significant events April-June 2025 During second quarter, Minesto continued operation and testing activities in Vestmanna, Faroe Islands. Since beginning of May, the… Continue reading Minesto publishes Half-Year Report 2025

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ — CEO Dr Martin Edlund: “As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and positive spirit than ever to deliver renewable tidal energy to the world” Significant events April-June 2025 During second quarter, Minesto continued operation and testing activities in Vestmanna, Faroe Islands. Since beginning of May, the… Continue reading Minesto publishes Half-Year Report 2025

TORM plc Q2 2025 Results, Dividend Distribution, and Financial Outlook 2025

HELLERUP, Denmark, Aug. 14, 2025 /PRNewswire/ — INSIDE INFORMATION “TORM delivered a strong second-quarter result with continued market-leading performance, against a backdrop of global uncertainty,” says Jacob Meldgaard, adding: “We see strong momentum heading into the second half of the year, and as a result, we are raising our full-year guidance.” Financial Results In the second… Continue reading TORM plc Q2 2025 Results, Dividend Distribution, and Financial Outlook 2025

Implantica publishes Interim Report January – June 2025 (Q2)

VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ —  Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed – Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to questions on the second module; Feedback on module 3… Continue reading Implantica publishes Interim Report January – June 2025 (Q2)

NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025

ANNOUNCEMENT NO. 163 – 14 AUGUST 2025 HELLERUP, Denmark, Aug. 14, 2025 /PRNewswire/ — Despite challenging market conditions, NORDEN delivered a net profit of USD 52 million (DKK 342 million) in the second quarter of 2025 and a return on invested capital of 10% LTM. In H1 2025, the net profit was USD 85 million,… Continue reading NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025

NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025

ANNOUNCEMENT NO. 163 – 14 AUGUST 2025 HELLERUP, Denmark, Aug. 14, 2025 /PRNewswire/ — Despite challenging market conditions, NORDEN delivered a net profit of USD 52 million (DKK 342 million) in the second quarter of 2025 and a return on invested capital of 10% LTM. In H1 2025, the net profit was USD 85 million,… Continue reading NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025

Navamedic ASA: Financial report for the 2nd quarter and first half of 2025

OSLO, Norway, Aug. 14, 2025 /PRNewswire/ — In the first half of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health, and hospital products to hospitals and pharmacies, delivered revenues of NOK 269.3 million, down from NOK 277.2 million in 2024. Excluding the milestone license fee from Orion… Continue reading Navamedic ASA: Financial report for the 2nd quarter and first half of 2025

Hexagon Composites ASA: Second quarter 2025

OSLO, Norway, Aug. 14, 2025 /PRNewswire/ — Hexagon Composites (OSE: HEX.OL), world leader in composite cylinder technology and related systems for storage and transportation of clean gaseous energy reported revenues of NOK 674 million for second quarter 2025 (Q2’24: 1 150 million). The reported EBITDA was NOK 12 million (Q2’24: NOK 137 million), resulting in… Continue reading Hexagon Composites ASA: Second quarter 2025

Max Stock Limited Reports Second Quarter and First Half 2025 Financial Results

Declares ILS 40 million (~ ILS 0.29 per share) One-Time Dividend Second Quarter Revenue Increased 6.1% to ILS 336.3 million; Comparable Store Sales Increased 4.2%; Gross Margin Increased 210 Basis Points; Adjusted EBITDA Increased 26.0% CAESAREA, Israel, Aug. 14, 2025 /PRNewswire/ — Max Stock Limited (TASE: MAXO) (the “Company”) today reported financial results for the… Continue reading Max Stock Limited Reports Second Quarter and First Half 2025 Financial Results